| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,660 |
4,268 |
$268K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,525 |
3,349 |
$133K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,031 |
2,022 |
$128K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,795 |
1,678 |
$72K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
518 |
498 |
$42K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,674 |
1,613 |
$39K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
660 |
660 |
$39K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
217 |
210 |
$16K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,965 |
1,864 |
$15K |
| 0002A |
|
203 |
203 |
$8K |
| 0001A |
|
178 |
178 |
$7K |
| 99051 |
|
1,629 |
1,586 |
$6K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
288 |
278 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
90 |
88 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
29 |
29 |
$3K |
| 87428 |
|
76 |
76 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
180 |
180 |
$2K |
| 99201 |
|
107 |
107 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
202 |
103 |
$2K |
| 0012A |
|
48 |
48 |
$2K |
| 90674 |
|
64 |
64 |
$1K |
| 0064A |
|
34 |
34 |
$1K |
| 0004A |
|
38 |
38 |
$1K |
| 99385 |
|
12 |
12 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
89 |
88 |
$1K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$983.87 |
| 80053 |
Comprehensive metabolic panel |
152 |
151 |
$859.44 |
| 0011A |
|
27 |
27 |
$723.52 |
| G0008 |
Administration of influenza virus vaccine |
98 |
98 |
$685.44 |
| 0013A |
|
17 |
17 |
$657.28 |
| 80061 |
Lipid panel |
220 |
219 |
$629.01 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
144 |
143 |
$545.36 |
| 80050 |
General health panel |
101 |
101 |
$542.11 |
| 82607 |
|
115 |
115 |
$531.40 |
| 0072A |
|
13 |
13 |
$528.64 |
| 0071A |
|
13 |
13 |
$525.76 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
147 |
146 |
$518.99 |
| 99072 |
|
1,782 |
1,567 |
$490.00 |
| 90686 |
|
35 |
35 |
$423.94 |
| 84443 |
Thyroid stimulating hormone (TSH) |
71 |
71 |
$373.23 |
| 36410 |
|
96 |
91 |
$355.91 |
| 0031A |
|
16 |
16 |
$267.58 |
| 81002 |
|
351 |
346 |
$217.30 |
| 99173 |
|
174 |
174 |
$208.22 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
39 |
38 |
$191.76 |
| 36415 |
Collection of venous blood by venipuncture |
919 |
905 |
$178.02 |
| 96127 |
|
58 |
58 |
$154.11 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
38 |
38 |
$146.81 |
| 99401 |
|
15 |
14 |
$121.71 |
| 84439 |
|
36 |
36 |
$97.37 |
| 84480 |
|
32 |
32 |
$84.32 |
| 91300 |
|
409 |
388 |
$0.00 |
| 99000 |
|
1,562 |
1,518 |
$0.00 |
| 91301 |
|
95 |
95 |
$0.00 |
| 91306 |
|
34 |
34 |
$0.00 |
| 91307 |
|
26 |
22 |
$0.00 |
| 91305 |
|
17 |
17 |
$0.00 |